Boston Scientific, a manufacturer of medical devices used in interventional medical specialties, completed the acquisition of Baylis Medical Company, a medical device company, for $1.75bn. "The close of this acquisition allows Boston Scientific to integrate the Baylis platforms with our existing electrophysiology and structural heart offerings, further strengthening our position within the highest growth cardiology markets. We are now the only company to pair a comprehensive access portfolio with existing left-heart therapies such as left atrial appendage closure and atrial fibrillation ablation, providing physicians with a complete toolbox to treat patients with safety, efficacy and efficiency," Joe Fitzgerald, Boston Scientific Executive Vice President.